University of Pittsburgh

Category

ACTIV-2 Clinical Trial Comes to University of Pittsburgh School of Medicine: Investigators Test LY-CoV555 & Potentially Ab8

The University of Pittsburgh School of Medicine (Pitt) represents one of 25 initiated trial site organizations investigating novel therapies targeting the earlier stages of COVID-19 in a bid to start focusing on early treatment to reduce disease progression. Pitt has...

University of Pittsburgh Secures $1m NIH Grant for Collaboration with Tiba Biotech Developing RNA-based COVID-19 Vaccine

Researchers at the University of Pittsburgh (Pitt) now pursue three COVID-19 vaccines, including 1) the PittCoVac announced by TrialSite News on April 3; 2) the investigational vaccine out of Pitt’s Center for Vaccine Research in collaboration with Austrian biotech...

University of Pittsburgh Joins Disruptive AI-based Federated Learning Network to Advance Clinical Research

The University of Pittsburgh has partnered with AI and Federated Learning technologies startup to help augment medical research and enable scientific discoveries. In first establishing a pilot agreement, the University of Pittsburgh will leverage its own high-quality...

CSL Behring & University City Science Center Accelerate Research for New Biotherapies with Grant Awards

University of Pittsburgh and University of Delaware researchers received funding for research covering innovative therapies targeting pulmonary fibrosis (FB) to Gene delivery to or editing Hematopoietic (blood) Stem and Progenitor Cells (HSPCs). Two clinical...

UPMC Study Evidences Open Heart Surgery Superior to Stents for More than One Blocked Artery

University of Pittsburgh Medical Center (UPMC)’s Suresh R. Mulukutla, MD led a study to determine whether coronary artery bypass grafting (CABG) surgery would outperform percutaneous coronary intervention (PCI).  The answer: Yes. The UPMC-led team disclosed that the...

Pin It on Pinterest